Product Images Cinqair
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Cinqair NDC 59310-610 by Teva Respiratory, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - image 1
This is a graphic representation of the probability of not experiencing an asthma exacerbation over time, comparing the effects of CINQAIR 3.0 mg/kg and placebo in a sample of 245 and 264 subjects respectively. The x-axis represents time to first asthma exacerbation in weeks, and the y-axis represents the probability of not experiencing an exacerbation.*
Figure 2 - image 2
This appears to be a chart indicating the LS (least squares) mean change from baseline in FEV1 (forced expiratory volume) in liters over various weeks of a clinical trial involving a placebo group and a treatment group receiving a medication called CINQAIR. The medication group had 103 participants and the placebo group had 105. There is a scale on the left indicating changes in FEV1 in liters, ranging from -0.5 to 0.2.*
trade carton image - image 3
This appears to be a description of a prescription medicine called CINQAIR (reslizumab) used for intravenous infusion. The dosage information is available on the package, and the medication must be refrigerated and is sterile. The injection contains 100 mg/10 mL of reslizumab and is diluted prior to administration. The medication is a treatment for nict_et. The text includes information about storage, expiration dates, and discarding unused portions.*
Sample Carton Image - image 4
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.